Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
That is all the official record says: Vergent Bioscience, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
No investor of Vergent Bioscience, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 27 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Vergent Bioscience, Inc.
Name
Role
Named in
Jeffrey T. Yurecko
Executive officer
Oct 2025
John T. Santini, Jr.
Executive officer
Oct 2025
Jeffrey Yurecko
Executive officer
Feb 2025
John Santini
Executive officer
Feb 2025
Jeffrey Dean Yurecko
Executive officer
Nov 2021
Anita T. Watkins
Director
Oct 2025
Bobby T. Helmedag
Director
Oct 2025
Douglas T. Kohrs
Director
Oct 2025
John T. Santini, Jr.
Director
Oct 2025
Raymond T. Wong
Director
Oct 2025
Anita Watkins
Ms. Wilson was elected as a Director on the Date of First Sale.
Feb 2025
Anita Wilson
Ms. Wilson was elected as a Director on the Date of First Sale.
Feb 2025
Bobby Helmedag
Director
Feb 2025
Douglas Kohrs
Director
Feb 2025
Jeff Julkowski
Mr. Julkowski was a Director on the date the board approved the offering. He resigned as a Director on the Date of First
Feb 2025
John Santini
Director
Feb 2025
Raymond Wong
Director
Feb 2025
Ryan Egeland
Mr. Egeland was a Director on the date the board approved the offering. He resigned as a Director on the Date of First S
Feb 2025
Samuel Dean Banks
Mr. Dean Banks was a Director on the date the board approved the offering. He resigned as a Director on the Date of Firs